Journal
PHARMACOLOGICAL REPORTS
Volume 74, Issue 4, Pages 709-717Publisher
SPRINGER HEIDELBERG
DOI: 10.1007/s43440-022-00371-2
Keywords
G protein-coupled receptor 35; GPR35; Colorectal cancer; Overall survival; Disease-specific survival; Biomarker
Categories
Funding
- Medical University of Lodz [503/1-156-04/503-11-001-19]
- Foundation for Polish Science (FNP) [START 30.2021]
Ask authors/readers for more resources
This study suggests that the expression of GPR35 is associated with survival rates in colorectal cancer patients and has prognostic value for male patients.
Background G protein-coupled receptor 35 (GPR35) is involved in the carcinogenesis; however, limited data exist on its relevance for overall survival (OS) and disease-specific survival (DSS) in patients with cancer. Methods We have examined The Cancer Genome Atlas dataset to check the relations between GPR35 expression pattern and OS or DSS of patients with colorectal cancer (CRC). Results The performed analysis showed a negative association between positive GPR35 expression Z score and OS in males, which remains statistically significant in advanced stages of colon (COAD) and rectal (READ) adenocarcinoma combined. Conclusions These findings suggest the prognostic value of early testing of GPR35 in male patients with an increased risk of CRC development and warrant further clinical confirmation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available